Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Teladoc Health, Inc.
Report date September 04, 2024 · Filed September 05, 2024
Section 16 reporting ended · disclosed 2024-09-05. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 20,773 |
Reported balance
After 2024-09-04 transaction · row 1
1 source rowRow 1 · 2024-09-04 · Sale · Disposed 20,773 · Balance 20,773 F1: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on June 4, 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on June 4, 2024.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 02, 2023 Filed Mar 3, 2023 16:18 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 437 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-004107 · form4-03032023_090316.xml · nonDerivative · entry 8 Turitz Andrew · CIK 0001726221 · SVP - CORPORATE DEVELOPMENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,601 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 16:18 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 867 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-004107 · form4-03032023_090316.xml · nonDerivative · entry 7 Turitz Andrew · CIK 0001726221 · SVP - CORPORATE DEVELOPMENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,164 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 16:18 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,147 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-004107 · form4-03032023_090316.xml · nonDerivative · entry 6 Turitz Andrew · CIK 0001726221 · SVP - CORPORATE DEVELOPMENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,297 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 16:18 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 515 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-004107 · form4-03032023_090316.xml · nonDerivative · entry 5 Turitz Andrew · CIK 0001726221 · SVP - CORPORATE DEVELOPMENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,150 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 16:18 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 2,048 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-004107 · form4-03032023_090316.xml · nonDerivative · entry 4 Turitz Andrew · CIK 0001726221 · SVP - CORPORATE DEVELOPMENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,635 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 16:18 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,205 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-004107 · form4-03032023_090316.xml · nonDerivative · entry 3 Turitz Andrew · CIK 0001726221 · SVP - CORPORATE DEVELOPMENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,587 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 16:18 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 1,801 | $25.36 | $45,676.96 |
DisclosureSEC source: 0001415889-23-004107 · form4-03032023_090316.xml · nonDerivative · entry 2 Turitz Andrew · CIK 0001726221 · SVP - CORPORATE DEVELOPMENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,382 F2 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 16:18 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 5,389 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004107 · form4-03032023_090316.xml · derivative · entry 9 Turitz Andrew · CIK 0001726221 · SVP - CORPORATE DEVELOPMENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,781 Underlying: Common Stock · 5,389 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F4 · derivative.exercise_date: On March 1, 2022, the reporting person was granted 16,170 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F4 · derivative.expiration_date: On March 1, 2022, the reporting person was granted 16,170 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 16:18 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 5,389 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-004107 · form4-03032023_090316.xml · nonDerivative · entry 1 Turitz Andrew · CIK 0001726221 · SVP - CORPORATE DEVELOPMENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,183 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 16:18 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantEmployee Stock Option (right to buy) · Derivative | 56,430 | $0.00 Strike: $32.62 | $0.00 |
DisclosureSEC source: 0001415889-22-006098 · form4-06032022_010637.xml · derivative · entry 1 Turitz Andrew · CIK 0001726221 · SVP - BUSINESS DEVELOPMENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,430 Underlying: Common Stock · 56,430 shares Expires 2032-05-31 F1 · derivative.exercise_date: The option will vest as to one-third of the shares on June 1, 2023. The remainder of the shares will vest in 24 substantially equal monthly installments thereafter. Read SEC document |
| March 07, 2022 Filed Mar 8, 2022 16:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 1,334 | $66.74 | $89,027.16 |
DisclosureSEC source: 0001179110-22-002051 · edgar.xml · nonDerivative · entry 3 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,794 F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit and performance stock unit awards. Read SEC document |
| March 04, 2022 Filed Mar 8, 2022 16:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 2,567 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-002051 · edgar.xml · derivative · entry 5 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,567 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F5 · derivative.exercise_date: On February 26, 2020, the reporting person earned 7,701 performance stock units, vesting in three substantially equal annual installments beginning on March 4, 2020. F5 · derivative.expiration_date: On February 26, 2020, the reporting person earned 7,701 performance stock units, vesting in three substantially equal annual installments beginning on March 4, 2020. Read SEC document |
| March 04, 2022 Filed Mar 8, 2022 16:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,974 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-002051 · edgar.xml · derivative · entry 4 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,974 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F4 · derivative.exercise_date: On March 4, 2019, the reporting person was granted 5,922 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. F4 · derivative.expiration_date: On March 4, 2019, the reporting person was granted 5,922 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 04, 2022 Filed Mar 8, 2022 16:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 2,567 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-22-002051 · edgar.xml · nonDerivative · entry 2 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,128 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 04, 2022 Filed Mar 8, 2022 16:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,974 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-22-002051 · edgar.xml · nonDerivative · entry 1 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,561 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 03, 2022 Filed Mar 4, 2022 18:34 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 1,754 | $70.24 | $123,199.21 |
DisclosureSEC source: 0001415889-22-002583 · form4-03042022_030324.xml · nonDerivative · entry 6 Turitz Andrew · CIK 0001726221 · SVP - BUSINESS DEVELOPMENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,587 F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit and performance stock unit awards. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 18:34 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 868 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-002583 · form4-03042022_030324.xml · derivative · entry 13 Turitz Andrew · CIK 0001726221 · SVP - BUSINESS DEVELOPMENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,734 Underlying: Common Stock · 868 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F13 · derivative.exercise_date: On March 2, 2022, the reporting person earned 2,602 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2022. F13 · derivative.expiration_date: On March 2, 2022, the reporting person earned 2,602 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2022. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 18:34 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantPerformance Stock Units · Derivative | 2,602 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-002583 · form4-03042022_030324.xml · derivative · entry 12 Turitz Andrew · CIK 0001726221 · SVP - BUSINESS DEVELOPMENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,602 Underlying: Common Stock · 2,602 shares Expires not disclosed F6 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of TDOC common stock. F11 · shares: Performance award amount determined based on metrics in respect of the issuer's 2021 financial results F12 · derivative.exercise_date: The performance stock units vest in three substantially equal annual installments beginning on March 2, 2022. F12 · derivative.expiration_date: The performance stock units vest in three substantially equal annual installments beginning on March 2, 2022. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 18:34 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,147 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-002583 · form4-03042022_030324.xml · derivative · entry 11 Turitz Andrew · CIK 0001726221 · SVP - BUSINESS DEVELOPMENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,295 Underlying: Common Stock · 1,147 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F10 · derivative.exercise_date: On March 2, 2021, the reporting person was granted 3,442 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. F10 · derivative.expiration_date: On March 2, 2021, the reporting person was granted 3,442 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 18:34 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 515 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-002583 · form4-03042022_030324.xml · derivative · entry 10 Turitz Andrew · CIK 0001726221 · SVP - BUSINESS DEVELOPMENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 515 Underlying: Common Stock · 515 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F9 · derivative.exercise_date: On March 2, 2022, the reporting person earned 1,030 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2022. F9 · derivative.expiration_date: On March 2, 2022, the reporting person earned 1,030 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2022. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 18:34 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantPerformance Stock Units · Derivative | 1,030 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-002583 · form4-03042022_030324.xml · derivative · entry 9 Turitz Andrew · CIK 0001726221 · SVP - BUSINESS DEVELOPMENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,030 Underlying: Common Stock · 1,030 shares Expires not disclosed F6 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of TDOC common stock. F7 · shares: Performance award amount determined based on metrics in respect of the issuer's financial results over a two-year performance period ending in 2021. F8 · derivative.exercise_date: The performance stock units vest in two substantially equal annual installments beginning on March 2, 2022. F8 · derivative.expiration_date: The performance stock units vest in two substantially equal annual installments beginning on March 2, 2022. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 18:34 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 2,050 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-002583 · form4-03042022_030324.xml · derivative · entry 8 Turitz Andrew · CIK 0001726221 · SVP - BUSINESS DEVELOPMENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,048 Underlying: Common Stock · 2,050 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F5 · derivative.exercise_date: On March 2, 2021, the reporting person earned 6,146 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2021. F5 · derivative.expiration_date: On March 2, 2021, the reporting person earned 6,146 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2021. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 18:34 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,205 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-002583 · form4-03042022_030324.xml · derivative · entry 7 Turitz Andrew · CIK 0001726221 · SVP - BUSINESS DEVELOPMENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,205 Underlying: Common Stock · 1,205 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F4 · derivative.exercise_date: On March 2, 2020, the reporting person was granted 3,615 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. F4 · derivative.expiration_date: On March 2, 2020, the reporting person was granted 3,615 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 18:34 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 868 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-22-002583 · form4-03042022_030324.xml · nonDerivative · entry 5 Turitz Andrew · CIK 0001726221 · SVP - BUSINESS DEVELOPMENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,341 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 18:34 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,147 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-22-002583 · form4-03042022_030324.xml · nonDerivative · entry 4 Turitz Andrew · CIK 0001726221 · SVP - BUSINESS DEVELOPMENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,473 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 18:34 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 515 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-22-002583 · form4-03042022_030324.xml · nonDerivative · entry 3 Turitz Andrew · CIK 0001726221 · SVP - BUSINESS DEVELOPMENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,326 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 18:34 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 2,050 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-22-002583 · form4-03042022_030324.xml · nonDerivative · entry 2 Turitz Andrew · CIK 0001726221 · SVP - BUSINESS DEVELOPMENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,811 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 18:34 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,205 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-22-002583 · form4-03042022_030324.xml · nonDerivative · entry 1 Turitz Andrew · CIK 0001726221 · SVP - BUSINESS DEVELOPMENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,761 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 16:37 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 16,170 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-001916 · edgar.xml · derivative · entry 1 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,170 Underlying: Common Stock · 16,170 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F2 · derivative.exercise_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F2 · derivative.expiration_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| March 08, 2021 Filed Mar 9, 2021 17:50 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 1,193 | $188.15 | $224,462.95 |
DisclosureSEC source: 0001179110-21-003153 · edgar.xml · nonDerivative · entry 3 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,556 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on April 20, 2020. Read SEC document |
| March 05, 2021 Filed Mar 9, 2021 17:50 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 2,155 | $183.18 | $394,761.52 |
DisclosureSEC source: 0001179110-21-003153 · edgar.xml · nonDerivative · entry 2 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,749 F2 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit and performance stock unit awards. Read SEC document |
| March 05, 2021 Filed Mar 9, 2021 17:50 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 511 | $194.15 | $99,210.65 |
DisclosureSEC source: 0001179110-21-003153 · edgar.xml · nonDerivative · entry 1 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,904 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on April 20, 2020. Read SEC document |
| March 04, 2021 Filed Mar 5, 2021 17:27 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 2,567 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-002988 · edgar.xml · derivative · entry 10 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,567 Underlying: Common Stock · 2,567 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F8 · derivative.exercise_date: On February 26, 2020, the reporting person earned 7,701 performance stock units, vesting in three substantially equal annual installments beginning on March 4, 2020. The number of performance stock units earned has been increased by two due to a rounding error on the reporting person's Form 4 that was filed on February 28, 2020. F8 · derivative.expiration_date: On February 26, 2020, the reporting person earned 7,701 performance stock units, vesting in three substantially equal annual installments beginning on March 4, 2020. The number of performance stock units earned has been increased by two due to a rounding error on the reporting person's Form 4 that was filed on February 28, 2020. F8 · balance_after: On February 26, 2020, the reporting person earned 7,701 performance stock units, vesting in three substantially equal annual installments beginning on March 4, 2020. The number of performance stock units earned has been increased by two due to a rounding error on the reporting person's Form 4 that was filed on February 28, 2020. Read SEC document |
| March 04, 2021 Filed Mar 5, 2021 17:27 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,974 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-002988 · edgar.xml · derivative · entry 9 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,974 Underlying: Common Stock · 1,974 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F7 · derivative.exercise_date: On March 4, 2019, the reporting person was granted 5,922 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. F7 · derivative.expiration_date: On March 4, 2019, the reporting person was granted 5,922 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 04, 2021 Filed Mar 5, 2021 17:27 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 2,567 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-21-002988 · edgar.xml · nonDerivative · entry 7 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,415 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 04, 2021 Filed Mar 5, 2021 17:27 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,974 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-21-002988 · edgar.xml · nonDerivative · entry 6 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,848 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 04, 2021 Filed Mar 5, 2021 17:27 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 834 | $200.48 | $167,196.15 |
DisclosureSEC source: 0001179110-21-002988 · edgar.xml · nonDerivative · entry 5 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,874 F5 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Read SEC document |
| March 04, 2021 Filed Mar 5, 2021 17:27 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 1,033 | $201.25 | $207,891.25 |
DisclosureSEC source: 0001179110-21-002988 · edgar.xml · nonDerivative · entry 4 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,708 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on April 20, 2020. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 17:27 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,856 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-002988 · edgar.xml · derivative · entry 8 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,856 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F4 · derivative.exercise_date: On May 25, 2017, the reporting person was granted 7,426 restricted stock units, vesting in four substantially equal annual installments beginning on March 3, 2018. F4 · derivative.expiration_date: On May 25, 2017, the reporting person was granted 7,426 restricted stock units, vesting in four substantially equal annual installments beginning on March 3, 2018. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 17:27 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,856 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-21-002988 · edgar.xml · nonDerivative · entry 3 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,741 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 17:27 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 1,188 | $206.99 | $245,904.12 |
DisclosureSEC source: 0001179110-21-002988 · edgar.xml · nonDerivative · entry 2 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,885 F2 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit and performance stock unit awards. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 17:27 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 805 | $214.63 | $172,777.15 |
DisclosureSEC source: 0001179110-21-002988 · edgar.xml · nonDerivative · entry 1 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,073 F1 · shares: This transaction was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on April 20, 2020. Read SEC document |
| March 02, 2021 Filed Mar 3, 2021 20:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 3,442 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-002810 · edgar.xml · derivative · entry 9 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,442 Underlying: Common Stock · 3,442 shares Expires not disclosed F10 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F11 · derivative.exercise_date: The restricted stock units vest in three substantially equal annual installments beginning on the first anniversary of the grant date. F11 · derivative.expiration_date: The restricted stock units vest in three substantially equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 02, 2021 Filed Mar 3, 2021 20:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionPerformance Stock Units · Derivative | 2,048 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-002810 · edgar.xml · derivative · entry 8 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,098 Underlying: Common Stock · 2,048 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. F9 · derivative.exercise_date: On March 2, 2021, the reporting person earned 6,146 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2021. F9 · derivative.expiration_date: On March 2, 2021, the reporting person earned 6,146 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2021. Read SEC document |
| March 02, 2021 Filed Mar 3, 2021 20:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantPerformance Stock Units · Derivative | 6,146 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-002810 · edgar.xml · derivative · entry 7 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,146 Underlying: Common Stock · 6,146 shares Expires not disclosed F6 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of TDOC common stock. F7 · shares: Performance award amount determined based on metrics in respect of the issuer's 2020 financial results. F8 · derivative.exercise_date: The performance stock units vest in three substantially equal annual installments beginning on March 2, 2021. F8 · derivative.expiration_date: The performance stock units vest in three substantially equal annual installments beginning on March 2, 2021. Read SEC document |
| March 02, 2021 Filed Mar 3, 2021 20:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 1,205 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-002810 · edgar.xml · derivative · entry 6 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,410 Underlying: Common Stock · 1,205 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F5 · derivative.exercise_date: On March 2, 2020, the reporting person was granted 3,615 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. F5 · derivative.expiration_date: On March 2, 2020, the reporting person was granted 3,615 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 02, 2021 Filed Mar 3, 2021 20:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 2,048 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-21-002810 · edgar.xml · nonDerivative · entry 4 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,878 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 02, 2021 Filed Mar 3, 2021 20:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,205 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-21-002810 · edgar.xml · nonDerivative · entry 3 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,830 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 02, 2021 Filed Mar 3, 2021 20:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 695 | $224.28 | $155,875.99 |
DisclosureSEC source: 0001179110-21-002810 · edgar.xml · nonDerivative · entry 2 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,625 F2 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 20:02 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 2,305 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-002810 · edgar.xml · derivative · entry 5 Turitz Andrew · CIK 0001726221 · SVP - Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,305 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F4 · derivative.exercise_date: On March 1, 2018, the reporting person was granted 6,914 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. F4 · derivative.expiration_date: On March 1, 2018, the reporting person was granted 6,914 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.